Skip to main content
Log in

A Novel Drug Delivery Carrier Based on α-eleostearic Acid Grafted Hydroxyapatite Composite

  • Published:
Journal of Bionic Engineering Aims and scope Submit manuscript

Abstract

The purpose of this study is to explore and develop a novel biocompatibility drug delivery carrier for controllingontrolled drug release. The α-eleostearic acid grafted hydroxyapatite (α-ESA-g-HA) composite was synthesized by using silane coupling agent and characterized by Fourier Transformation Infrared Spectroscopy (FT-IR), Thermal Gravimetric Analysis (TGA) and Scanning Electron Microscope (SEM), respectively. The in vitro drug loading and controlled release behaviors of α-ESA-g-HA composite were investigated using ciprofloxacin as the model drug. The amount of ciprofloxacin loading and released was calculated by absorbance value which was determined by UV-Vis spectrophotometry at wavelength of 277 nm. The biocompatibility of α-ESA-g-HA composite was assessed by 3-(4,5)-dimethylthiahiazo(-z-yl)-3,5-di-phenytetrazoliumromide(MTT) assay, nuclear morphology and platelet adhesion. The results showed that the α-ESA-g-HA had nontoxic and good biocompatibility. According to the results mentioned above, the α-ESA-g-HA is an effective drug delivery carrier, which could increase drug loading capacity and control drug release, so further studies are necessary to evaluate clinical application and human health care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Langer R. New methods of drug delivery. Science, 1990, 249, 1527–1533.

    Article  Google Scholar 

  2. Huang Y C, Lam U I. Chitosan/fucoidan pH sensitive nanoparticles for oral delivery system. Journal of the Chinese Chemical Society, 2011, 58, 779–785.

    Article  Google Scholar 

  3. Slowing I I, Vivero-Escoto J L, Wu C W, Lin V S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Reviews, 2008, 60, 1278–1288.

    Article  Google Scholar 

  4. Xiao B L, Ma Z Y, Bl J. Creep behavior of TiBw/Ti and (TiBw + TiCp)/Ti in situ composite. Journal of Materials Science Letters, 2002, 21, 859–861.

    Article  Google Scholar 

  5. Peter M, Ganesh N, Selvamurugan N, Nair S V, Furuike T, Tamura H, Jayakumar R. Preparation and characterization of chitosangelatin/nanohydroxyapatite composite scaffolds for tissue engineering applications. Carbohydrate Polymers, 2010, 80, 687–694.

    Article  Google Scholar 

  6. Nie H, Wang C H. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. Journal of controlled release, 2007, 120, 111–121.

    Article  Google Scholar 

  7. Saleem I Y, Vordermeier M, Barralet J E, Coombes A G. Improving peptide-based assays to differentiate between vaccination and Mycobacterium bovis infection in cattle using nanoparticle carriers for adsorbed antigens. Journal of controlled release, 2005, 102, 551–561.

    Article  Google Scholar 

  8. Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusun-ose T, Toyonaga T, Hamada Y, Takahashi J. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials, 2004, 25, 3807–3812.

    Article  Google Scholar 

  9. Sibilla P, Sereni A, Aguiari G, Banzi M, Manzati E, Mischiati C, Trombelli L, del Senno L. Effects of a hydroxyapa-tite-based biomaterial on gene expression in osteoblast-like cells. Journal of Dental Research, 2006, 85, 354–358.

    Article  Google Scholar 

  10. Dasgupta S, Bandyopadhyay A, Bose S. Reverse micelle-mediated synthesis of calcium phosphate nanocarriers for release of bovine serum albumin. Acta Biomaterialia, 2009, 5, 3112–3121.

    Article  Google Scholar 

  11. Liu T Y, Chen S Y, Liu D M, Liou S C. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery. Journal of Controlled Release, 2005, 107,112–121.

    Article  Google Scholar 

  12. Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi C L. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Advanced Functional Materials, 2007, 17, 2180–2188.

    Article  Google Scholar 

  13. Zhu X, Eibl O, Scheideler L, Geis-Gerstorfer J. Characterization of nano hydroxyapatite/collagen surfaces cellular behaviors. Journal Biomedical Materials Reseach A, 2006, 79, 114–127.

    Article  Google Scholar 

  14. Zhu X L, Eibl O, Berthold C, Scheideler, L, Geis-Gerstorfer. Some fundamental aspects of mechanics of nanocomposite materials and structural members. Journal of Nanotechnol-ogy, 2006, 17, 2711–2721.

    Article  Google Scholar 

  15. Cai Y, Liu Y, Yan W, Hu Q, Tao J, Zhang M, Shi Z, Tang R. Role of hydroxyapatite nanoparticle size in bone cell proliferation. Journal of Materials Chemistry, 2007, 17, 3780–3787.

    Article  Google Scholar 

  16. Y Mizushima, T Ikoma, J Tanaka, K Hoshi, T Ishihara, Y Ogawa, A Ueno. Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. Journal of Controlled Release, 2006, 110, 260–265.

    Article  Google Scholar 

  17. Liu Q, De Wijn J R, Bakker D, Van Blitterswijk C A. Surface modification of hydroxyapatite to introduce interfacial bonding with polyactiveTM 70/30 in a biodegradable composite. Journal of Materials science: Materials in Medicine, 1996, 7, 551–557.

    Google Scholar 

  18. Murugan R, Ramakrishna S. Coupling of therapeutic molecules onto surface modified coralline hydroxyapatite. Biomaterials, 2004, 25, 3073–3080.

    Article  Google Scholar 

  19. D’Andrea S C, Fadeev A Y. Covalent surface modification of calcium hydroxyapatite using n-Alkyl- and n-Fluoroalky-lphosphonic acids. Langmuir, 2003, 19, 7904–7910.

    Article  Google Scholar 

  20. Borum-Nicholas L, Wilson Jr O C. Surface modification hydroxyapatite. Part I. Dodecyl alcohol. Biomaterials, 2003, 24, 3671–3679.

    Article  Google Scholar 

  21. Vega E D, Narda G E, Ferretti F H. Adsorption of citric acid from dilute aqueous solutions by hydroxyapatite. Journal of Colloid and Interface Science, 2003, 268, 37–42.

    Article  Google Scholar 

  22. Borum L, Wilson Jr O C. Surface modification of hydroxyapatite. Part II. Silica. Biomaterials, 2003, 24, 3681–3688.

    Article  Google Scholar 

  23. Liu Q, de Wijn J R, van Blitterswijk C A. Covalent bonding of PMMA, PBMA, and poly(HEMA) to hydroxyapatite particles. Journal of Biomedical Material Research, 1998, 40, 257–263.

    Article  Google Scholar 

  24. Liu Q, de Wijn J R, de Groot K, van Blitterswijk C A. Surface modification of nano-apatite by grafting organic polymer. Biomaterials, 1998, 19, 1067–1072.

    Article  Google Scholar 

  25. Theresa B, Price S L. Dimer or catemer? Lowenergy crystal packings for small carboxylic acids. Journal Physical Chemistry, 2000, 104, 2647–2655.

    Article  Google Scholar 

  26. Eom J M, Seo M J, Baek J Y, Chu H, Han S H, Min T S, Cho C S, Yun C H. Alpha-eleostearic acid induces autophagy-dependent cell death through targeting AKT/mTOR and ERK1/2 signal together with the generation of reactive oxygen species. Biochemical and Biophysical Research Communications, 2010, 391, 903–908.

    Article  Google Scholar 

  27. Zhou H, Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomaterialia, 2011, 7, 2769–2781.

    Article  Google Scholar 

  28. öner M, Yetiz E, Ay E. Ibuprofen release from porous hy-droxyapatite tablets. Ceramics International, 2011, 37, 2117–2125.

    Article  Google Scholar 

  29. Cosijns A, Vervaet C, Luyten J, Mullens S, Siepmann F, Van Hoorebeke L, Masschaele B, Cnudde V, Remon J P. Porous hydroxyapatite tablets as carriers for low-dosed drugs. European Journal of Pharmaceutics and Biopharmaceutics, 2007, 67, 498–506.

    Article  Google Scholar 

  30. Baradari H, Damia C, Dutreih-Colas M, Laborde E, Pecout N, Champion E, Chulia D, Viana M. Calcium phosphate porous pellets as drug delivery systems: Effect of drug carrier composition on drug loading and in vitro release. Journal of the European Ceramic Society, 2012, 32, 2679–2690.

    Article  Google Scholar 

  31. öner M, Yetiz E, Ay E. Ibuprofen release from porous hy-droxyapatite tablets. Ceramics International, 2011, 37, 2117–2125.

    Article  Google Scholar 

  32. Gbureck U, Vorndran E, Müller F A, Barralet J E. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. Journal of Controlled Release, 2007, 122, 173–180.

    Article  Google Scholar 

  33. Lu P, Fan H, Liu Y, Cao L, Wu X, Xu X. Controllable bio-degradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents. Colloids and Surfaces B: Biointerfaces, 2011, 83, 23–28.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jingchan Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, T., Tang, W., Zhao, J. et al. A Novel Drug Delivery Carrier Based on α-eleostearic Acid Grafted Hydroxyapatite Composite. J Bionic Eng 11, 125–133 (2014). https://doi.org/10.1016/S1672-6529(14)60027-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1672-6529(14)60027-5

Keywords

Navigation